These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27291145)

  • 1. Treatment of hyperthyroidism with antithyroid drugs corrects mild neutropenia in Graves' disease.
    Aggarwal N; Tee SA; Saqib W; Fretwell T; Summerfield GP; Razvi S
    Clin Endocrinol (Oxf); 2016 Dec; 85(6):949-953. PubMed ID: 27291145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutropenia Occurs More Often Under Carbimazole than Under Methimazole Treatment in Pediatric Graves' Disease Patients.
    Schempp V; Cebeci AN; Reinauer C; Woelfle J; Dörr HG; Roosen MT; Gohlke J; Gohlke B
    Thyroid; 2024 Jun; 34(6):735-743. PubMed ID: 38613811
    [No Abstract]   [Full Text] [Related]  

  • 3. Antithyroid drugs in Graves' hyperthyroidism: differences between "block and replace" and "titration" regimes in frequency of euthyroidism and Graves' orbitopathy during treatment.
    Žarković M; Wiersinga W; Perros P; Bartalena L; Donati S; Okosieme O; Morris D; Fichter N; Lareida J; Daumerie C; Burlacu MC; Kahaly GJ; Pitz S; Beleslin B; Ćirić J; Ayvaz G; Konuk O; Törüner FB; Salvi M; Covelli D; Curro N; Hegedüs L; Brix T;
    J Endocrinol Invest; 2021 Feb; 44(2):371-378. PubMed ID: 32524368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum granulocyte colony-stimulating factor levels in patients with Graves' disease.
    Iitaka M; Noh JY; Kitahama S; Fukasawa N; Miura S; Kawakami Y; Kawasaki S; Yamanaka K; Ishii J; Katayama S; Ito K
    Clin Endocrinol (Oxf); 1998 Mar; 48(3):275-80. PubMed ID: 9578815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Anti-Thyroid Medications in Patients with Graves' Disease.
    Mahzari MM; Alanazi MM; Alabdulkareem YM; Alharbi WA; Alzahrani AS; Alqahtani NA; Ajwah IM; Ardah HI
    BMC Endocr Disord; 2024 Sep; 24(1):180. PubMed ID: 39237901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Second Antithyroid Drug Treatment Is Effective in Relapsed Graves' Disease Patients: A Median 11-Year Follow-Up Study.
    Kim YA; Cho SW; Choi HS; Moon S; Moon JH; Kim KW; Park DJ; Yi KH; Park YJ; Cho BY
    Thyroid; 2017 Apr; 27(4):491-496. PubMed ID: 28001121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
    Kumeda Y; Inaba M; Tahara H; Kurioka Y; Ishikawa T; Morii H; Nishizawa Y
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for the Relapse of Graves' Disease Treated With Antithyroid Drugs: A Systematic Review and Meta-analysis.
    Shi H; Sheng R; Hu Y; Liu X; Jiang L; Wang Z; Cui D
    Clin Ther; 2020 Apr; 42(4):662-675.e4. PubMed ID: 32139177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High neutrophil-to-lymphocyte ratio is associated with relapse in Graves' disease after antithyroid drug therapy.
    Kim M; Kim BH; Jang MH; Kim JM; Kim EH; Jeon YK; Kim SS; Kim IJ
    Endocrine; 2020 Feb; 67(2):406-411. PubMed ID: 31749116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When should antithyroid drug therapy to reduce the relapse rate of hyperthyroidism in Graves' disease be discontinued?
    Park S; Song E; Oh HS; Kim M; Jeon MJ; Kim WG; Kim TY; Shong YK; Kim DM; Kim WB
    Endocrine; 2019 Aug; 65(2):348-356. PubMed ID: 31236779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of the effectiveness of 131-I and antithyroid drugs in the treatment of Graves' disease in children].
    Chen DY; Chen TH
    Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):507-9. PubMed ID: 16083551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Modality and Risk of Heart Failure in Patients With Long-Standing Graves' Disease: A Nationwide Population-Based Cohort Study.
    Song E; Kim M; Park S; Park MJ; Kim JA; Roh E; Yu JH; Kim NH; Seo JA; Kim SG; Kim NH; Choi KM; Baik SH; Yoo HJ
    Front Endocrinol (Lausanne); 2021; 12():761782. PubMed ID: 34690936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic Response to Anti-thyroid Drugs in Graves' Hyperthyroidism.
    Abbara A; Clarke SA; Brewster R; Simonnard A; Eng PC; Phylactou M; Papadopoulou D; Izzi-Engbeaya C; Sam AH; Wernig F; Jonauskyte E; Comninos AN; Meeran K; Kelsey TW; Dhillo WS
    Front Endocrinol (Lausanne); 2020; 11():286. PubMed ID: 32477269
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of recurrent hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.
    Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
    J Endocrinol Invest; 1995 Jun; 18(6):415-9. PubMed ID: 7594234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction for recurrence following antithyroid drug therapy for Graves' hyperthyroidism.
    Weng H; Tian WB; Xiao ZD; Xu L
    Arch Endocrinol Metab; 2023 May; 67(4):e000609. PubMed ID: 37252698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymic hyperplasia is accurate to detect new-onset Graves' hyperthyroidism and resolves after restoring euthyroidism.
    Scappaticcio L; Caruso P; Di Martino N; Ferrazzano P; Clemente A; Maiorino MI; Regginelli A; Docimo G; Rambaldi PF; Bellastella G; Trimboli P; Cappabianca S; Esposito K
    J Endocrinol Invest; 2024 Oct; 47(10):2487-2497. PubMed ID: 38553585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of iodine-131-induced early thyroid hormone variations in Graves' disease.
    Xu F; Gu A; Pan Y; Yang L; Ma Y
    Nucl Med Commun; 2016 Nov; 37(11):1154-9. PubMed ID: 27366942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of pregnancy on subsequent relapse from Graves' disease after a successful course of antithyroid drug therapy.
    Rotondi M; Cappelli C; Pirali B; Pirola I; Magri F; Fonte R; Castellano M; Rosei EA; Chiovato L
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3985-8. PubMed ID: 18664537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion of the immature B lymphocyte compartment in Graves' disease.
    Lane LC; Cheetham TD; Razvi S; Allinson K; Pearce SHS
    Eur J Endocrinol; 2023 Aug; 189(2):208-216. PubMed ID: 37536284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with severe Graves' ophthalmopathy have a higher risk of relapsing hyperthyroidism and are unlikely to remain in remission.
    Eckstein AK; Lax H; Lösch C; Glowacka D; Plicht M; Mann K; Esser J; Morgenthaler NG
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):607-12. PubMed ID: 17880407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.